Brief: Vyne Therapeutics Announces Positive Results From Phase 1A Single And Multiple Ascending Dose Trial

YARROW BIOSCIENCE

15/02/2023 14:01

Feb 15 (Reuters) - Vyne Therapeutics Inc  VYNE.O :
    * VYNE THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM PHASE 1A
SINGLE AND MULTIPLE ASCENDING DOSE TRIAL FOR INVESTIGATIONAL
NOVEL BET INHIBITOR VYN201
    * VYNE THERAPEUTICS INC - VYN201 WAS GENERALLY
WELL-TOLERATED WITH
NO CLINICALLY RELEVANT TREATMENT EMERGENT ADVERSE EVENTS FROM
ALL DOSE COHORTS
    * VYNE THERAPEUTICS INC - TOPLINE PHASE 1B RESULTS IN
VITILIGO
PATIENTS EXPECTED IN MID-2023
    * VYNE THERAPEUTICS INC - VYN201 MET PRIMARY OBJECTIVE OF
STUDY

Source text for Eikon:  ID:nGNX5pVkxS 
Further company coverage:  VYNE.O 
 ((Reuters.briefs@thomsonreuters.com;))